150 related articles for article (PubMed ID: 8968050)
1. The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes.
Lepley DM; Li B; Birt DF; Pelling JC
Carcinogenesis; 1996 Nov; 17(11):2367-75. PubMed ID: 8968050
[TBL] [Abstract][Full Text] [Related]
2. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
Lepley DM; Pelling JC
Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
[TBL] [Abstract][Full Text] [Related]
3. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
McVean M; Weinberg WC; Pelling JC
Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
[TBL] [Abstract][Full Text] [Related]
4. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.
Wang W; Heideman L; Chung CS; Pelling JC; Koehler KJ; Birt DF
Mol Carcinog; 2000 Jun; 28(2):102-10. PubMed ID: 10900467
[TBL] [Abstract][Full Text] [Related]
5. Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells.
Sato F; Matsukawa Y; Matsumoto K; Nishino H; Sakai T
Biochem Biophys Res Commun; 1994 Oct; 204(2):578-84. PubMed ID: 7980517
[TBL] [Abstract][Full Text] [Related]
6. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells.
Choi YH; Zhang L; Lee WH; Park KY
Int J Oncol; 1998 Aug; 13(2):391-6. PubMed ID: 9664138
[TBL] [Abstract][Full Text] [Related]
7. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
Choi YH; Lee WH; Park KY; Zhang L
Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
[TBL] [Abstract][Full Text] [Related]
8. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
9. Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines.
Suzuki M; Hosaka Y; Matsushima H; Goto T; Kitamura T; Kawabe K
Cancer Lett; 1999 Apr; 138(1-2):121-30. PubMed ID: 10378783
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
12. Influence of vehicle, distant topical delivery, and biotransformation on the chemopreventive activity of apigenin, a plant flavonoid, in mouse skin.
Li B; Pinch H; Birt DF
Pharm Res; 1996 Oct; 13(10):1530-4. PubMed ID: 8899846
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte G2/M growth arrest by 1,25-dihydroxyvitamin D3 is caused by Cdc2 phosphorylation through Wee1 and Myt1 regulation.
Dai X; Yamasaki K; Yang L; Sayama K; Shirakata Y; Tokumara S; Yahata Y; Tohyama M; Hashimoto K
J Invest Dermatol; 2004 Jun; 122(6):1356-64. PubMed ID: 15175024
[TBL] [Abstract][Full Text] [Related]
14. Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain.
Roublevskaia IN; Polevoda BV; Ludlow JW; Haake AR
Anticancer Res; 2000; 20(5A):3163-7. PubMed ID: 11062738
[TBL] [Abstract][Full Text] [Related]
15. Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex.
Zhang XH; Zou ZQ; Xu CW; Shen YZ; Li D
Mol Med Rep; 2011; 4(2):273-7. PubMed ID: 21468563
[TBL] [Abstract][Full Text] [Related]
16. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes.
McVean M; Xiao H; Isobe K; Pelling JC
Carcinogenesis; 2000 Apr; 21(4):633-9. PubMed ID: 10753197
[TBL] [Abstract][Full Text] [Related]
17. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.
O'Connor PM; Ferris DK; Pagano M; Draetta G; Pines J; Hunter T; Longo DL; Kohn KW
J Biol Chem; 1993 Apr; 268(11):8298-308. PubMed ID: 8463339
[TBL] [Abstract][Full Text] [Related]
18. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest.
Ujiki MB; Ding XZ; Salabat MR; Bentrem DJ; Golkar L; Milam B; Talamonti MS; Bell RH; Iwamura T; Adrian TE
Mol Cancer; 2006 Dec; 5():76. PubMed ID: 17196098
[TBL] [Abstract][Full Text] [Related]
19. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines.
Wang W; VanAlstyne PC; Irons KA; Chen S; Stewart JW; Birt DF
Nutr Cancer; 2004; 48(1):106-14. PubMed ID: 15203384
[TBL] [Abstract][Full Text] [Related]
20. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
Minemoto Y; Uchida S; Ohtsubo M; Shimura M; Sasagawa T; Hirata M; Nakagama H; Ishizaka Y; Yamashita K
Arch Biochem Biophys; 2003 Apr; 412(1):13-9. PubMed ID: 12646262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
